Literature DB >> 29917185

MicroRNA-212 participates in the development of prostate cancer by upregulating BMI1 via NF-κB pathway.

H-W Qu1, Y Jin, Z-L Cui, X-B Jin.   

Abstract

OBJECTIVE: To investigate the role of microRNA-212 in prostate cancer (PCa) and its underlying mechanism. PATIENTS AND METHODS: MicroRNA-212 expressions in 72 PCa tissues and paracancerous tissues were detected by qRT-PCR (quantitative real-time polymerase chain reaction). The relationship between microRNA-212 expression and clinical characteristics of PCa patients was analyzed. Target genes of microRNA-212 were predicted by TargetScan and verified by luciferase reporter gene assay. Proliferation, cell cycle, and apoptosis of PCa cells were detected after transfection with corresponding plasmids of microRNA-212 in PCa cells, respectively. The effect of microRNA-212 on BMI1 and NF-κB pathway was detected by Western blot.
RESULTS: MicroRNA-212 was downregulated in PCa patients. The survival rate of PCa patients with lower expression of microRNA-212 was remarkably lower than those with a higher level. After overexpression of microRNA-212, we observed inhibited proliferation and arrested cell cycle of PCa cells. Increased apoptosis was found after PCa cells were transfected with microRNA-212 mimic. Luciferase reporter gene assay showed that microRNA-212 was bound to BMI1, which further promoted PCa development via NF-κB pathway.
CONCLUSIONS: MicroRNA-212 was downregulated in PCa tissues, which could promote the PCa development by targeting BMI1 via NF-κB pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29917185     DOI: 10.26355/eurrev_201806_15155

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

Review 1.  The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy.

Authors:  Wenjun Chen; Jing Song; Hongjun Bian; Xia Yang; Xiaoyu Xie; Qiang Zhu; Chengyong Qin; Jianni Qi
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

Review 2.  Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response.

Authors:  Milad Ashrafizadeh; Mahshid Deldar Abad Paskeh; Sepideh Mirzaei; Mohammad Hossein Gholami; Ali Zarrabi; Farid Hashemi; Kiavash Hushmandi; Mehrdad Hashemi; Noushin Nabavi; Francesco Crea; Jun Ren; Daniel J Klionsky; Alan Prem Kumar; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-03-22

Review 3.  MiR-212 value in prognosis and diagnosis of cancer and its association with patient characteristics: a systematic review and meta-analysis.

Authors:  Sara Raji; Mehrdad Sahranavard; Mahdi Mottaghi; Amirhossein Sahebkar
Journal:  Cancer Cell Int       Date:  2022-04-26       Impact factor: 6.429

4.  Negative feedback loop of ERK/CREB/miR-212-3p inhibits HBeAg-induced macrophage activation.

Authors:  Wenjun Chen; Hongjun Bian; Xiaoyu Xie; Xia Yang; Benjun Bi; Chunliu Li; Yuejuan Zhang; Qiang Zhu; Jing Song; Chengyong Qin; Jianni Qi
Journal:  J Cell Mol Med       Date:  2020-08-07       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.